GLP-1 medications can be highly effective for appropriately selected patients, but they are prescription treatments with real side effects, limitations, costs, and unanswered questions
Human evidence, by contrast, remains very limited
Sarcopenia and sarcopenic obesity and mortality among older people
By activating receptors for both GIP and GLP-1, these drugs can help reduce appetite , promote weight loss, and improve blood sugar control
Sustained demand, combined with online marketing that Health Canada says has misused its branding, underpins the department's renewed verification guidance